Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Rightway, founded in 2017 and headquartered in New York, is a technology and services company focused on improving the healthcare experience. The company offers a platform that streamlines healthcare processes for clients and members, making it more accessible and manageable. Operating in the Mobile Software & Services industry within the healthcare sector, Rightway has shown significant growth since its inception.
The company has successfully raised a total of $238.75 million across multiple funding rounds, with its most recent Series D round in March 2024 securing $108.75 million from investors including Khosla Ventures and Thrive Capital. This substantial funding history demonstrates strong investor confidence in Rightway's business model and growth potential. In its 2021 Series C round, Rightway achieved a reported valuation of $1.1 billion, marking its entry into unicorn status.
While there is no concrete information available regarding Rightway's IPO prospects, the company's impressive funding history and valuation growth may position it as an attractive candidate for going public in the future. However, it's important to note that many factors can influence a company's decision to pursue an IPO, including market conditions, financial performance, and strategic objectives.
Rightway operates in a competitive landscape, with rivals such as Accolade, Eden Health, and HealthJoy also working to innovate in the healthcare technology space. The company's ability to differentiate itself and maintain strong growth in this competitive environment could be crucial factors in any potential future IPO considerations.
As with any private company, investors interested in Rightway should keep in mind that plans for an IPO, if any, remain speculative until officially announced by the company or regulatory filings are made public.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Rightway's IPO prospects remain uncertain, investors eager to gain exposure to innovative healthcare technology companies don't have to wait. At Linqto, we offer members access to interests in pre-IPO private companies, including potential leaders in the healthcare and benefits management sectors. Our platform allows you to diversify your portfolio with lower minimum investments in promising companies like Rightway, potentially benefiting from their growth before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
